Works matching IS 13524585 AND DT 2019 AND VI 25

Results: 279

Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1942, doi. 10.1177/1352458518810261

By:

Hyun, Jae-Won;
Kim, Yeseul;
Kim, Gayoung;
Kim, Su-Hyun;
Kim, Ho Jin

Publication type:

Article

Regulatory B cells: The key to post-alemtuzumab rebound phenomena in multiple sclerosis?

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1945, doi. 10.1177/1352458518810258

By:

Hardy, Todd A

Publication type:

Article

Month-of-birth-effect in multiple sclerosis in Austria.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1870, doi. 10.1177/1352458518810924

By:

Walleczek, Nina-Katharina;
Frommlet, Florian;
Bsteh, Gabriel;
Eggers, Christian;
Rauschka, Helmut;
Koppi, Stefan;
Assar, Hamid;
Ehling, Rainer;
Birkl, Christoph;
Salhofer-Polanyi, Sabine;
Baumgartner, Anna;
Blechinger, Stephan;
Buchinger, Dominic;
Sellner, Johann;
Kraus, Jörg;
Moser, Hermann;
Mayr, Markus;
Guger, Michael;
Rathmaier, Sandra;
Raber, Bettina

Publication type:

Article

Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1937, doi. 10.1177/1352458518786072

By:

Shirani, Afsaneh;
Sun, Peng;
Schmidt, Robert E;
Trinkaus, Kathryn;
Naismith, Robert T;
Song, Sheng-Kwei;
Cross, Anne H

Publication type:

Article

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1896, doi. 10.1177/1352458518810260

By:

Schoonhoven, Deborah N;
Fraschini, Matteo;
Tewarie, Prejaas;
Uitdehaag, Bernard MJ;
Eijlers, Anand JC;
Geurts, Jeroen JG;
Hillebrand, Arjan;
Schoonheim, Menno M;
Stam, Cornelis J;
Strijbis, Eva MM

Publication type:

Article

Introducing the Barancik Prize lecture series.

Published in:

2019

By:

Coetzee, Timothy;
Bebo, Bruce

Publication type:

Editorial

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Commentary.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1845, doi. 10.1177/1352458519885110

By:

Arrambide, Georgina;
Tintore, Mar

Publication type:

Article

Remyelination and ageing: Reversing the ravages of time.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1835, doi. 10.1177/1352458519884006

By:

Neumann, Bjoern;
Segel, Michael;
Chalut, Kevin J;
Franklin, Robin JM

Publication type:

Article

Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1848, doi. 10.1177/1352458519879094

By:

Wojcik, Curtis M;
Beier, Meghan;
Costello, Kathleen;
DeLuca, John;
Feinstein, Anthony;
Goverover, Yael;
Gudesblatt, Mark;
Jaworski III, Michael;
Kalb, Rosalind;
Kostich, Lori;
LaRocca, Nicholas G;
Rodgers, Jonathan D;
Benedict, Ralph HB

Publication type:

Article

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Yes.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1842, doi. 10.1177/1352458519855723

By:

Rojas, Juan Ignacio;
Patrucco, Liliana;
Cristiano, Edgardo

Publication type:

Article

The MSBase registry: Informing clinical practice.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1828, doi. 10.1177/1352458519848965

By:

Kalincik, Tomas;
Butzkueven, Helmut

Publication type:

Article

An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – No.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1843, doi. 10.1177/1352458519845111

By:

Chard, Declan T;
Trip, S Anand

Publication type:

Article

Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1888, doi. 10.1177/1352458518815797

By:

London, Frédéric;
Zéphir, Hélène;
Hadhoum, Nawal;
Lannoy, Julien;
Vermersch, Patrick;
Pruvo, Jean-Pierre;
Hodel, Jérôme;
Leclerc, Xavier;
Outteryck, Olivier

Publication type:

Article

Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1878, doi. 10.1177/1352458518815597

By:

Filippatou, Angeliki;
Shoemaker, Thomas;
Esch, Megan;
Qutab, Madiha;
Gonzalez-Caldito, Natalia;
Prince, Jerry L;
Mowry, Ellen M;
Calabresi, Peter A;
Saidha, Shiv;
Sotirchos, Elias S

Publication type:

Article

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1926, doi. 10.1177/1352458518815596

By:

Chien, Claudia;
Scheel, Michael;
Schmitz-Hübsch, Tanja;
Borisow, Nadja;
Ruprecht, Klemens;
Bellmann-Strobl, Judith;
Paul, Friedemann;
Brandt, Alexander U

Publication type:

Article

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1915, doi. 10.1177/1352458518814117

By:

Elliott, Colm;
Wolinsky, Jerry S;
Hauser, Stephen L;
Kappos, Ludwig;
Barkhof, Frederik;
Bernasconi, Corrado;
Wei, Wei;
Belachew, Shibeshih;
Arnold, Douglas L

Publication type:

Article

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1907, doi. 10.1177/1352458518811597

By:

Oliveira, Luana Michelli;
Apóstolos-Pereira, Samira Luisa;
Pitombeira, Milena Sales;
Bruel Torretta, Pedro Henrique;
Callegaro, Dagoberto;
Sato, Douglas Kazutoshi

Publication type:

Article

Response to de Groot 'There is an urgent need for palliative care specialists in MS – Commentary'.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1821, doi. 10.1177/1352458519876697

By:

Cheong, Wing Loong;
Mohan, Devi;
Warren, Narelle;
Reidpath, Daniel D

Publication type:

Article

Response to Grech et al.: FLOUX-PMS study sample considerations.

Published in:

2019

By:

Mostert, Jop P;
De Keyser, Jacques

Publication type:

Letter

Letter to the editor: FLOUX-PMS study sample considerations.

Published in:

2019

By:

Grech, Lisa B;
Butler, Ernest;
Stuckey, Stephen;
Hester, Robert

Publication type:

Letter

There is an urgent need for palliative care specialists in MS – Commentary.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1713, doi. 10.1177/1352458519864935

By:

de Groot, Vincent

Publication type:

Article

The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials.

Published in:

2019

By:

Chataway, Jeremy;
Weir, Christopher J;
Fox, Robert J

Publication type:

Editorial

There is an urgent need for palliative care specialists in MS – No.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1712, doi. 10.1177/1352458519855724

By:

Vanopdenbosch, Ludo J;
Cambron, Melissa

Publication type:

Article

Three-dimensional MRI sequences in MS diagnosis and research.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1700, doi. 10.1177/1352458519848100

By:

Hu, Xun Yang;
Rajendran, Luckshi;
Lapointe, Emmanuelle;
Tam, Roger;
Li, David;
Traboulsee, Anthony;
Rauscher, Alexander

Publication type:

Article

Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1728, doi. 10.1177/1352458519843051

By:

Cambron, Melissa;
Mostert, Jop;
D'Hooghe, Marie;
Nagels, Guy;
Willekens, Barbara;
Debruyne, Jan;
Algoed, Luc;
Verhagen, Wim;
Hupperts, Raymond;
Heersema, Dorothea;
De Keyser, Jacques;
De Groot, Liesbeth;
De Bruyne, Jan;
Foselle, Erwin;
Guillaume, Daniel;
Merckx, Henri;
Vanopdenbosch, Ludo;
Vokaer, Mathieu;
Klippel, Nina De;
Nuytten, Dirk

Publication type:

Article

There is an urgent need for palliative care specialists in MS – Yes.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1710, doi. 10.1177/1352458519841827

By:

Solari, Alessandra;
Pucci, Eugenio

Publication type:

Article

Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1791, doi. 10.1177/1352458518810159

By:

Healy, Brian C;
Zurawski, Jonathan;
Gonzalez, Cindy T;
Chitnis, Tanuja;
Weiner, Howard L;
Glanz, Bonnie I

Publication type:

Article

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1746, doi. 10.1177/1352458518809903

By:

Achiron, Anat;
Sarova-Pinhas, Ida;
Magalashvili, David;
Stern, Yael;
Gal, Aviva;
Dolev, Mark;
Menascu, Shay;
Harari, Gil;
Gurevich, Michael

Publication type:

Article

International consensus on quality standards for brain health-focused care in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1809, doi. 10.1177/1352458518809326

By:

Hobart, Jeremy;
Bowen, Amy;
Pepper, George;
Crofts, Harriet;
Eberhard, Lucy;
Berger, Thomas;
Boyko, Alexey;
Boz, Cavit;
Butzkueven, Helmut;
Celius, Elisabeth Gulowsen;
Drulovic, Jelena;
Flores, José;
Horáková, Dana;
Lebrun-Frénay, Christine;
Marrie, Ruth Ann;
Overell, James;
Piehl, Fredrik;
Rasmussen, Peter Vestergaard;
Sá, Maria José;
Sîrbu, Carmen-Adella

Publication type:

Article

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1781, doi. 10.1177/1352458518808204

By:

Strober, Lauren;
DeLuca, John;
Benedict, Ralph HB;
Jacobs, Adam;
Cohen, Jeffrey A;
Chiaravalloti, Nancy;
Hudson, Lynn D;
Rudick, Richard A;
LaRocca, Nicholas G

Publication type:

Article

Cognitive-motor interference in persons with multiple sclerosis during five upper limb motor tasks with different complexity.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1736, doi. 10.1177/1352458518808194

By:

Raats, Joke;
Lamers, Ilse;
Baert, Ilse;
Willekens, Barbara;
Veldkamp, Renee;
Feys, Peter

Publication type:

Article

Diet quality and risk of multiple sclerosis in two cohorts of US women.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1773, doi. 10.1177/1352458518807061

By:

Rotstein, Dalia L;
Cortese, Marianna;
Fung, Teresa T;
Chitnis, Tanuja;
Ascherio, Alberto;
Munger, Kassandra L

Publication type:

Article

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1800, doi. 10.1177/1352458518806103

By:

Ahmad, Hasnat;
van der Mei, Ingrid;
Taylor, Bruce V;
Lucas, Robyn M;
Ponsonby, Anne-Louise;
Lechner-Scott, Jeannette;
Dear, Keith;
Valery, Patricia;
Clarke, Philip M;
Simpson, Steve;
Palmer, Andrew J

Publication type:

Article

PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East Italy.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1719, doi. 10.1177/1352458518803273

By:

Tateo, Fabio;
Grassivaro, Francesca;
Ermani, Mario;
Puthenparampil, Marco;
Gallo, Paolo

Publication type:

Article

Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1764, doi. 10.1177/1352458518802544

By:

Bose, Gauruv;
Atkins, Harold L;
Bowman, Marjorie;
Freedman, Mark S

Publication type:

Article

Age is a critical determinant in recovery from multiple sclerosis relapses.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1754, doi. 10.1177/1352458518800815

By:

Conway, Brittani L;
Zeydan, Burcu;
Uygunoğlu, Uğur;
Novotna, Martina;
Siva, Aksel;
Pittock, Sean J;
Atkinson, Elizabeth J;
Rodriguez, Moses;
Kantarci, Orhun H

Publication type:

Article

Multiple sclerosis disease progression: Contributions from a hypoxia–inflammation cycle.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1715, doi. 10.1177/1352458518791683

By:

Yang, Runze;
Dunn, Jeff F

Publication type:

Article

PML with dimethyl fumarate—No role for natalizumab?

Published in:

2019

By:

Berger, Joseph R

Publication type:

Letter

PML with dimethyl fumarate—No convincing case against natalizumab.

Published in:

2019

By:

Diebold, Martin;
Altersberger, Valerian;
Décard, Bernhard F;
Kappos, Ludwig;
Derfuss, Tobias;
Lorscheider, Johannes

Publication type:

Letter

High alert!

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1685, doi. 10.1177/1352458519858603

By:

Clifford, David B

Publication type:

Article

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1682, doi. 10.1177/1352458519852100

By:

Diebold, Martin;
Altersberger, Valerian;
Décard, Bernhard F;
Kappos, Ludwig;
Derfuss, Tobias;
Lorscheider, Johannes

Publication type:

Article

Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteria.

Published in:

2019

By:

Arrambide, Georgina;
Tintore, Mar;
Montalban, Xavier

Publication type:

Letter

Changes in the sex ratio are a good indicator of changes in MS incidence – Commentary.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1570, doi. 10.1177/1352458519845114

By:

Pugliatti, Maura

Publication type:

Article

The emergence of follow-on disease-modifying therapies for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1560, doi. 10.1177/1352458519845106

By:

Moss, Brandon P;
Cohen, Jeffrey A

Publication type:

Article

Daclizumab-induced encephalitis in multiple sclerosis.

Published in:

2019

By:

Bianchi, Alessia;
Ciccarelli, Olga

Publication type:

Editorial

Changes in the sex ratio are a good indicator of changes in MS incidence – Yes.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1566, doi. 10.1177/1352458519838780

By:

Ajdacic-Gross, Vladeta;
von Wyl, Viktor

Publication type:

Article

Changes in the sex ratio are a good indicator of changes in MS incidence – No.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1568, doi. 10.1177/1352458519837926

By:

Magyari, Melinda;
Koch-Henriksen, Nils

Publication type:

Article

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1618, doi. 10.1177/1352458518819098

By:

Stork, Lidia;
Brück, Wolfgang;
von Gottberg, Phillip;
Pulkowski, Ulrich;
Kirsten, Florian;
Glatzel, Markus;
Rauer, Sebastian;
Scheibe, Franziska;
Radbruch, Helena;
Hammer, Eckhard;
Stürner, Klarissa H;
Kaulen, Barbara;
Heesen, Christoph;
Hoffmann, Frank;
Brock, Sebastian;
Pawlitzki, Marc;
Bopp, Tobias;
Metz, Imke

Publication type:

Article

Therapeutic drug monitoring of natalizumab.

Published in:

2019

By:

Tanaka, Masami

Publication type:

Letter

Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.

Published in:

Multiple Sclerosis Journal, 2019, v. 25, n. 12, p. 1633, doi. 10.1177/1352458518799598

By:

Antonazzo, Ippazio Cosimo;
Poluzzi, Elisabetta;
Forcesi, Emanuele;
Riise, Trond;
Bjornevik, Kjetil;
Baldin, Elisa;
Muratori, Luigi;
De Ponti, Fabrizio;
Raschi, Emanuel

Publication type:

Article